Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, September 17, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Fluidigm and Olink Bioscience Bring New Level of Protein Biomarker Discovery
Friday, August 02, 2013
96 samples across 92 proteins in one microfluidic run.

Diagnosis of Parvovirus B19 in Pregnancy Enhanced
Monday, July 29, 2013
The Iam Parvo assay is a rapid quantitative molecular assay that expands DiaSorin's diagnostic portfolio for this potentially life-threatening virus.

Bio-Rad Introduces the QX200 Droplet Digital PCR System
Monday, July 29, 2013
Bio-Rad Laboratories, Inc. announced the launch of its QX200 Droplet Digital™ PCR (ddPCR) system, the second generation of the company's Droplet Digital™ PCR technology.

Bio-Rad Introduces New Digital PCR Assays for Human Copy Number Variation and Mutation Detection
Wednesday, July 10, 2013
Bio-Rad Laboratories, Inc. announced the launch of its PrimePCR™ assays for Droplet Digital™ PCR.

Bio-Rad Offers New PrimePCR™ Probe Assays for Human and Mouse Genomes
Friday, July 05, 2013
Expertly designed PrimePCR real-time PCR primers are experimentally validated for assured performance.

Streamlining PCR Assay Design with the IDT PrimerQuest® Design Tool
Wednesday, July 03, 2013
Free online tool enhances PCR primer and probe design with new upgrades.

An Easy-to-Use, Affordable Cell Sorter for Core Facilities and Individual Research Labs
Wednesday, June 26, 2013
Bio-Rad Laboratories, Inc. announced the launch of its S3 cell sorter, an automated benchtop cell sorter that even novices find easy to use.

Multiplex qPCR: IDT Covers How To Get Started
Tuesday, June 11, 2013
Get multiplex qPCR right first time, with this useful advice guide in DECODED.

Roche Launches New Software Updates
Friday, June 07, 2013
New software tools for the LightCycler 96 and LightCycler Nano systems.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 583
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv